Netherlands· NL-b3d69e4fe18e
Micafungine Accord 50 mg poeder voor concentraat voor oplossing voor infusie
A micafungin product containing micafungine natrium, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Micafungin is registered in 17 of 19 countries.
Countries holding a registration under ATC J02AX05 (micafungin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Micafungin · ATC J02AX05
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MICAFUNGINE NATRIUM
- Manufacturer
- Accord Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- J02AX05
- ATC class
- Micafungin
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id129884
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
12 interactions on record for micafungin.
Graded by severity as the source publishes them — 12 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Micafungin · interactions on record
12 records
- 12 moderate
Most severe, free to view
- Amphotericin BA07AA07moderate
- NitisinoneA16AX04moderate
- Amphotericin BJ02AA01moderate
- RibociclibL01EF02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Micafungin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceMICAFUNGINE HIKMA 50 mg, poudre pour solution à diluer pour perfusionHIKMA FARMACEUTICA (PORTUGAL)
- United StatesMicafunginZydus Pharmaceuticals USA Inc.
- PolandMicafungin AccordAccord Healthcare Polska Sp. z o.o.
- SpainMICAFUNGINA ACCORD 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- United KingdomMicafungin 100mg powder for concentrate for solution for infusion vialsWockhardt UK Ltd
- SwedenMicafungin Accord 100 mg Pulver till koncentrat till infusionsvätska, lösningAccord Healthcare B.V.
- CanadaMICAFUNGIN SODIUM FOR INJECTIONJUNO PHARMACEUTICALS CORP.
- CzechiaMICAFUNGIN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Micafungin Biocon, Micafungin Hikma
- Belgium · Micafungine Hikma
- Bulgaria · Микафунгин Tzf, Микафунгин Ромфарм
- Cyprus · Micafungin Accord, Micafungin Pharmazac
- Czechia · Micafungin Accord, Micafungin Agmed
- Germany · Micafungin, Micafungin Hikma
- Denmark · Micafungin ”hikma”
- Estonia · Micafungin Pharmazac, Micafungin Tzf
- Spain · Micafungina Accord, Micafungina Accordpharma
- Finland · Micafungin Accord, Micafungin Hikma
- France · Micafungine Accord, Micafungine Hikma
- United Kingdom (Northern Ireland) · Micafungin Accord-Uk, Micafungin Aft Pharma Uk
- Greece · Funzoren, Micafungin Anfarm
- Croatia · Micafungin Accord, Mikafungin Pharmazac
- Hungary · Micafungin Pharma D&s, Micafungin Pharmazac 100 Mg
- Iceland · Mycamine
- Italy · Micafungina Accord, Micafungina Hikma
- Liechtenstein · Mycamine
- Lithuania · Micafungin Accord, Micafungin Pharmazac
- Latvia · Micafungin Accord, Micafungin Pharmazac 100 Mg
- Malta · Funzoren, Micafungin Anfarm
- Norway · Micafungin Accord, Micafungin Hikma
- Poland · Micafungin Accord, Micafungin Pharmazac, 100 Mg
- Portugal · Micafungin Accordpharma, Micafungina Accord
- Romania · Micafungin Pharmazac, Micafungin Rompharm
- Sweden · Micafungin Accord, Micafungin Bioglan
- Slovenia · Mikafungin Accord, Mikafungin Pharmazac
- Slovakia · Micafungin Accord, Micafungin Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/faba56ef-6517-494c-a5d0-db03357e9d14 GET /v1/drugs/faba56ef-6517-494c-a5d0-db03357e9d14?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129884_smpc.pdf",
"strength": null,
"atc_label": "Micafungin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129884",
"excipients": [
"CITROENZUUR 0-WATER (E 330)",
"LACTOSE 1-WATER",
"NATRIUMHYDROXIDE (E 524)",
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"MICAFUNGINE NATRIUM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129884.pdf",
"authorised_at": "2024/03/19",
"procedure_number": "FI/H/1169/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "129884",
"additional_monitoring": "N"
}See everything about micafungin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.